| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kim Hanjoon Alex | Chief Financial Officer | C/O STANDARD BIOTOOLS INC., 2 TOWER PLACE, STE 2000, SOUTH SAN FRANCISCO | /s/ Hanjoon Alex Kim by Tomone Tanaka, Attorney-in-Fact | 2025-05-30 | 0001919209 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Tax liability | -$2.82K | -2.58K | -0.28% | $1.09 | 928K | May 28, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on March 24, 2025. |